Proteomics

Dataset Information

0

Anti-necroptotic effects of human Wharton’s jelly-derived mesenchymal stem cells in skeletal muscle cell death model via secretion of GRO-α


ABSTRACT: Human mesenchymal stem cells (hMSCs) have therapeutic applications and potential for use in regenerative medicine. However, the use of hMSCs in research and clinical medicine is limited by a lack of information pertaining to their donor-specific functional attributes. In this study, we compared the characteristics of same-donor derived placenta (PL) and Wharton’s jelly (WJ)-derived hMSCs, we also compared their mechanism of action in a skeletal muscle disease in vitro model. The effects of GRO-α were also investigated in a Duchenne muscular dystrophy (DMD) mouse model. The same-donor-derived hWJ- and hPL-MSCs exhibited typical hMSC characteristics. GRO-α was differentially expressed in hWJ- and hPL-MSCs. However, when the secretion of GRO-α was considered, hWJ-MSCs displayed a higher ability to inhibit necroptosis in skeletal muscle cells than hPL-MSCs. This demonstrates the anti-necroptotic therapeutic effect of GRO-α in the skeletal muscle cell death model. Furthermore, considering their potential to inhibit necroptosis in skeletal muscle cells, hWJ-MSCs and the derived GRO-α are novel treatment options for skeletal muscle diseases such as DMD.

ORGANISM(S): Mus musculus Homo sapiens

PROVIDER: GSE277126 | GEO | 2024/09/25

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2020-02-05 | PXD014893 | Pride
2021-12-01 | PXD027772 | Pride
2020-01-09 | PXD016003 | Pride
2009-07-04 | E-GEOD-13073 | biostudies-arrayexpress
2020-08-15 | GSE156267 | GEO
2004-02-04 | E-GEOD-1007 | biostudies-arrayexpress
2004-02-04 | GSE1007 | GEO
2021-09-08 | PXD015355 | Pride
2011-01-13 | GSE26567 | GEO
2022-11-04 | GSE210799 | GEO